Markus Graefen

81.2k total citations · 8 hit papers
927 papers, 26.6k citations indexed

About

Markus Graefen is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, Markus Graefen has authored 927 papers receiving a total of 26.6k indexed citations (citations by other indexed papers that have themselves been cited), including 761 papers in Pulmonary and Respiratory Medicine, 217 papers in Surgery and 167 papers in Rheumatology. Recurrent topics in Markus Graefen's work include Prostate Cancer Diagnosis and Treatment (637 papers), Prostate Cancer Treatment and Research (579 papers) and Urologic and reproductive health conditions (151 papers). Markus Graefen is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (637 papers), Prostate Cancer Treatment and Research (579 papers) and Urologic and reproductive health conditions (151 papers). Markus Graefen collaborates with scholars based in Germany, Canada and Italy. Markus Graefen's co-authors include Hartwig Huland, Francesco Montorsi, Pierre I. Karakiewicz, Alexander Haese, Thorsten Schlomm, Felix K.‐H. Chun, Thomas Steuber, Alberto Briganti, Shahrokh F. Shariat and Jochen Walz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Markus Graefen

885 papers receiving 26.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Retropubic, Laparoscopic, and Robot-Assisted Radical Prostatectomy: A Systematic Review and Cumulative Analysis of Comparative Studies

2009 695 citations Markus Graefen, Giorgio Guazzoni et al. profile →
Systematic Review and Meta-analysis of Studies Reporting Potency Rates After Robot-assisted Radical Prostatectomy

2012 523 citations Markus Graefen, Giorgio Guazzoni et al. profile →
Reporting and Grading of Complications After Urologic Surgical Procedures: An ad hoc EAU Guidelines Panel Assessment and Recommendations

2011 446 citations Markus Graefen et al. profile →
Distribution of metastatic sites in renal cell carcinoma: a population-based analysis

2011 434 citations Maxine Sun, Shahrokh F. Shariat et al. profile →
Systematic Review and Meta-analysis of Studies Reporting Oncologic Outcome After Robot-assisted Radical Prostatectomy

2012 357 citations Peter R. Carroll, Markus Graefen et al. profile →
Systematic Review and Meta-analysis of Perioperative Outcomes and Complications After Robot-assisted Radical Prostatectomy

2012 350 citations Markus Graefen, Giorgio Guazzoni et al. profile →
Initial Experience of 68Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy

2015 337 citations Lars Budäus, Sami‐Ramzi Leyh‐Bannurah et al. profile →
Positive Surgical Margins After Radical Prostatectomy: A Systematic Review and Contemporary Update

2013 305 citations Alberto Briganti, Markus Graefen et al. profile →

Peers

Countries citing papers authored by Markus Graefen

Since Specialization

Citations

This map shows the geographic impact of Markus Graefen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Graefen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Graefen more than expected).

Fields of papers citing papers by Markus Graefen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Graefen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Graefen. The network helps show where Markus Graefen may publish in the future.

Co-authorship network of co-authors of Markus Graefen

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Graefen. A scholar is included among the top collaborators of Markus Graefen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Graefen. Markus Graefen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomes 2025 ·World Journal of Urology ·(unknown), Mattia Longoni, Andrea Marmiroli, Fabian Falkenbach, (unknown), (unknown), (unknown), Jordan A. Goyal, Fred Saad, Riccardo Schiavina, Luca Carmignani, Alberto Briganti, Nicola Longo, Markus Graefen, Carlotta Palumbo, (unknown), Felix K.‐H. Chun, Pierre I. Karakiewicz	0
2	Preventative Function-sparing Radical Prostatectomy: Experience in a Tertiary Referral Centre 2025 ·European Urology Oncology ·Alexander Haese, Markus Graefen, (unknown), Felix Preißer	0
3	Bimodal imaging: Detection rate of clinically significant prostate cancer is higher in MRI lesions visible to transrectal ultrasound 2024 ·The Prostate ·Fabian Falkenbach, (unknown), (unknown), Dirk Beyersdorff, Daniel Köehler, Francesca Ambrosini, (unknown), Tobias Maurer, Markus Graefen, Lars Budäus	0
4	Survival after trimodal therapy in octogenarians with organ‐confined urothelial bladder cancer 2024 ·British Journal of Urology ·Mattia Longoni, Francesco Di Bello, Natali Rodriguez Peñaranda, Fabian Falkenbach, Andrea Marmiroli, (unknown), Zhe Tian, Jordan A. Goyal, Nicola Longo, Salvatore Micali, Markus Graefen, Gennaro Musi, Felix K.‐H. Chun, Fred Saad, Shahrokh F. Shariat, Marco Moschini, Giorgio Gandaglia, Francesco Montorsi, (unknown), Pierre I. Karakiewicz	1
5	Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active Treatment 2024 ·Journal of the National Comprehensive Cancer Network ·Reha‐Baris Incesu, Simone Morra, (unknown), Andrea Baudo, Letizia Maria Ippolita Jannello, Mario de Angelis, Carolin Siech, (unknown), Zhe Tian, Fred Saad, Shahrokh F. Shariat, Felix K.‐H. Chun, Alberto Briganti, Ottavio De Cobelli, Luca Carmignani, Sascha Ahyai, Nicola Longo, Derya Tilki, Markus Graefen, Pierre I. Karakiewicz	1
6	Comparative analysis of robot-assisted and open approach for PSMA-radioguided surgery in recurrent prostate cancer 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·Francesca Ambrosini, Fabian Falkenbach, Lars Budäus, Thomas Steuber, Markus Graefen, Daniel Köehler, Sophie Knipper, Tobias Maurer	4
7	Regional differences in total hospital costs for radical cystectomy in the United States 2023 ·Surgical Oncology ·Benedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, Gabriele Sorce, Francesco Chierigo, Andrea Panunzio, Zhe Tian, Fred Saad, Michele Gallucci, Alberto Briganti, Carlo Terrone, Shahrokh F. Shariat, Markus Graefen, Derya Tilki, Alessandro Antonelli, Luis A. Kluth, Andreas Becker, Felix K.‐H. Chun, Pierre I. Karakiewicz	11
8	New Bioactive β-Resorcylic Acid Derivatives from the Alga-Derived Fungus Penicillium antarcticum KMM 4685 2023 ·Marine Drugs ·(unknown), Alexandr S. Antonov, (unknown), Jessica Hauschild, Olesya I. Zhuravleva, Yuliya V. Khudyakova, (unknown), Roman S. Popov, (unknown), Markus Graefen, Carsten Bokemeyer, Gunhild von Amsberg, Anton N. Yurchenko, Sergey A. Dyshlovoy	9
9	Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for Biochemical Failure After Radical Prostatectomy 2023 ·European Urology Focus ·(unknown), Derya Tilki, Jean Feng, Hartwig Huland, Markus Graefen, Thomas Wiegel, Dirk Böhmer, Julian C. Hong, Gilmer Valdés, Janet E. Cowan, Matthew R. Cooperberg, Felix Y. Feng, (unknown), Mohamed Shelan, Anthony V. D’Amico, Peter R. Carroll, Osama Mohamad	3
10	Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death 2023 ·Journal of Clinical Oncology ·Derya Tilki, Ming‐Hui Chen, Jing Wu, Hartwig Huland, Markus Graefen, Osama Mohamad, Janet E. Cowan, Felix Y. Feng, Peter R. Carroll, Anthony V. D’Amico	24
11	Association of very low PSA with increased metastases and death in patients with biopsy Gleason score 8-10 prostate cancer 2020 ·European Urology Open Science ·Raisa S. Pompe, Felix Preißer, Sami‐Ramzi Leyh‐Bannurah, Philipp Gild, Georg Salomon, Markus Graefen, Michael Fisch, Hartwig Huland, Derya Tilki	1
12	State-of-the-art weakly supervised automated classification of prostate cancer tissue microarrays via deep learning: Can sufficient accuracy be achieved without manual patch level annotation? 2020 ·European Urology Open Science ·(unknown), (unknown), (unknown), Valérie Ouellet, (unknown), (unknown), (unknown), Markus Graefen, Lars Budäus, Pierre I. Karakiewicz, Dominique Trudel, (unknown)	1
13	Impact of positive surgical margin length and Gleason grade at the margin on oncologic outcomes in patients with non-organ-confined prostate cancer 2020 ·European Urology Open Science ·Felix Preißer, Alexander Heinze, Raisa S. Pompe, Felix K.‐H. Chun, Markus Graefen, Hartwig Huland, Derya Tilki	1
14	Contemporary approach to predict early biochemical recurrence after radical prostatectomy: update of the Walz nomogram 2018 ·Prostate Cancer and Prostatic Diseases ·Raisa S. Pompe, Marco Bandini, Felix Preißer, Michele Marchioni, Emanuele Zaffuto, Zhe Tian, Georg Salomon, Thorsten Schlomm, Hartwig Huland, Markus Graefen, Derya Tilki, Shahrokh F. Shariat, Pierre I. Karakiewicz	10
15	First North American validation and head‐to‐head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy 2017 ·British Journal of Urology ·Marco Bandini, Michele Marchioni, Raisa S. Pompe, Zhe Tian, Giorgio Gandaglia, Nicola Fossati, Firas Abdollah, Markus Graefen, Francesco Montorsi, Fred Saad, Shahrokh F. Shariat, Alberto Briganti, Pierre I. Karakiewicz	28
16	Differences in Patient Characteristics among Men Choosing Open or Robot-Assisted Radical Prostatectomy in Contemporary Practice - Analysis of Surveillance, Epidemiology, and End Results Database 2016 ·Urologia Internationalis ·Jonas Schiffmann, Alessandro Larcher, Maxine Sun, Zhe Tian, (unknown), (unknown), Hugues Widmer, Jean-Baptiste Lattouf, Kevin C. Zorn, Alexander Haese, Shahrokh F. Shariat, Fred Saad, Francesco Montorsi, Markus Graefen, Pierre I. Karakiewicz	16
17	Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer 2015 ·Clinical Cancer Research ·Christoph Burdelski, (unknown), Claudia Hube‐Magg, Martina Kluth, Sarah Minner, Christina Koop, Markus Graefen, Hans Heinzer, Maria Christina Tsourlakis, Corinna Wittmer, Hartwig Huland, Ronald Simon, Thorsten Schlomm, Guido Sauter, Stefan Steurer	39
18	Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer 2014 ·European Journal of Surgical Oncology ·Alessandro Larcher, Maxine Sun, Jonas Schiffmann, Zhe Tian, Shahrokh F. Shariat, Michael McCormack, Fred Saad, Nicola Fossati, Firas Abdollah, Alberto Briganti, Nicolò Maria Buffi, Markus Graefen, Giorgio Guazzoni, Francesco Montorsi, Pierre I. Karakiewicz	28
19	CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer 2013 ·Cancer Research ·Lia Burkhardt, (unknown), Antje Krohn, Sawinee Masser, Malte Mäder, Martina Kluth, (unknown), Hartwig Huland, Thomas Steuber, Markus Graefen, Thorsten Schlomm, Sarah Minner, Guido Sauter, Hüseyin Sirma, Ronald Simon	130
20	Interphase cytogenetic study of preoperative core biopsies for the prediction of early serum prostate specific antigen recurrence after radical prostatectomy of clinically localized prostate carcinoma 1998 ·Cancer ·Rolf‐Peter Henke, Peter Hammerer, Markus Graefen, Andreas Erbersdobler, (unknown), (unknown), Hartwig Huland	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact